More Woes for the Stem Cell Initiative In California | GenomeWeb

David Hamilton at Venture Beat covers the latest events at CIRM, the California Institute for Regenerative Medicine. While the $3 billion stem cell program has started disbursing funds to scientists, bad news continues to hound the endeavor. Most recently, Arlene Chiu, the interim chief scientific officer, resigned unexpectedly, Hamilton writes. Her departure follows on the heels of the resignation earlier this year of Zach Hall, CIRM's first president.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.